Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

351 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL.
Rejeski K, Perez A, Iacoboni G, Penack O, Bücklein V, Jentzsch L, Mougiakakos D, Johnson G, Arciola B, Carpio C, Blumenberg V, Hoster E, Bullinger L, Locke FL, von Bergwelt-Baildon M, Mackensen A, Bethge W, Barba P, Jain MD, Subklewe M. Rejeski K, et al. J Immunother Cancer. 2022 May;10(5):e004475. doi: 10.1136/jitc-2021-004475. J Immunother Cancer. 2022. PMID: 35580927 Free PMC article.
Overcoming tumor-mediated immunosuppression.
Schlößer HA, Theurich S, Shimabukuro-Vornhagen A, Holtick U, Stippel DL, von Bergwelt-Baildon M. Schlößer HA, et al. Immunotherapy. 2014;6(9):973-88. doi: 10.2217/imt.14.58. Immunotherapy. 2014. PMID: 25341119 Review.
Cytokine release syndrome.
Shimabukuro-Vornhagen A, Gödel P, Subklewe M, Stemmler HJ, Schlößer HA, Schlaak M, Kochanek M, Böll B, von Bergwelt-Baildon MS. Shimabukuro-Vornhagen A, et al. J Immunother Cancer. 2018 Jun 15;6(1):56. doi: 10.1186/s40425-018-0343-9. J Immunother Cancer. 2018. PMID: 29907163 Free PMC article. Review.
[Challenges in Immuno-Oncology - Possibilities for Optimization].
Shimabukuro-Vornhagen A, Subklewe M, von Bergwelt-Baildon M. Shimabukuro-Vornhagen A, et al. Dtsch Med Wochenschr. 2018 Jul;143(14):1022-1029. doi: 10.1055/a-0549-6987. Epub 2018 Jul 13. Dtsch Med Wochenschr. 2018. PMID: 30005436 German.
NKT cells - New players in CAR cell immunotherapy?
Kriegsmann K, Kriegsmann M, von Bergwelt-Baildon M, Cremer M, Witzens-Harig M. Kriegsmann K, et al. Eur J Haematol. 2018 Dec;101(6):750-757. doi: 10.1111/ejh.13170. Epub 2018 Oct 9. Eur J Haematol. 2018. PMID: 30187578 Review.
Teaching an old dog new tricks: next-generation CAR T cells.
Tokarew N, Ogonek J, Endres S, von Bergwelt-Baildon M, Kobold S. Tokarew N, et al. Br J Cancer. 2019 Jan;120(1):26-37. doi: 10.1038/s41416-018-0325-1. Epub 2018 Nov 9. Br J Cancer. 2019. PMID: 30413825 Free PMC article. Review.
Advances in cancer immunotherapy 2019 - latest trends.
Kruger S, Ilmer M, Kobold S, Cadilha BL, Endres S, Ormanns S, Schuebbe G, Renz BW, D'Haese JG, Schloesser H, Heinemann V, Subklewe M, Boeck S, Werner J, von Bergwelt-Baildon M. Kruger S, et al. J Exp Clin Cancer Res. 2019 Jun 19;38(1):268. doi: 10.1186/s13046-019-1266-0. J Exp Clin Cancer Res. 2019. PMID: 31217020 Free PMC article. Review.
[Immuno-Oncology Meets Intensive Care Medicine: CAR-T cells].
Böll B, Borrega JG, Schellongowski P, Subklewe M, von Bergwelt-Baildon M. Böll B, et al. Dtsch Med Wochenschr. 2019 Sep;144(19):1342-1347. doi: 10.1055/a-0853-4689. Epub 2019 Sep 26. Dtsch Med Wochenschr. 2019. PMID: 31559615 Review. German.
351 results